Upside, Downside Movers in the Morning
Upside:
-ENTX +66% (prices $275M private placement of 135M shares and pre-funded warrants at $2.04/shr for osteoporosis program)
-FBRX +40% (to be acquired by Argenx at $77/shr for $2.2B to add FB102 for vitiligo and celiac disease)
-TRAX +34% (higher in sympathy with FBRX)
-AGPU +17% (awarded 5-yr, >$1.5B US AI infrastructure contract for >9,200 NVIDIA Blackwell B300 GPUs)
-FRNM +7.7% (receives FDA premarket approval for SimpleScreen CRC test)
-SRPT +7.1% (appoints Michael Severino CEO)
-QBTS +7.0% (hearing Benchmark Company Resumed QBTS with Buy, price target: $30; expands AT&T quantum computing use)
-BE +4.6% (strength ahead of quarterly earnings report)
-RKLB +4.1% (awarded $266M multi-launch contract by U.S. Space Force)
-AAL +4.0% (airline rally with crude prices lower following President Trump delaying Iran operation)
-LUV +3.6% (airline rally with crude prices lower following President Trump delaying Iran operation)
-INSG +3.5% (Inseego Subscribe achieves CMMC Level 2 certification)
-BKR +3.2% (earnings, guidance)
-RIVN +3.2% (Piper/Sandler Raised RIVN to Overweight from Neutral, price target: $20)
-DAL +2.9% (airline rally with crude prices lower following President Trump delaying Iran operation)
-CVU +2.8% (awarded $13.6M L3Harris contract for NGJ-LB pod structures)
-CDRE +2.7% (JPMorgan Chase and Co Initiates CDRE with Overweight, price target: $40)
-SNDK +2.7% (momentum)
-CRCL +2.4% (acquires IBM blockchain patent portfolio)
Downside:
-CAPR -61% (FDA staff review says data for CAPR’s Duchenne cell therapy doesn’t provide substantial evidence of effectiveness)
-MPLT -58% (reports Phase 2 ZEPHYR data for ML-007C-MA in acute exacerbation of schizophrenia)
-PFSA -18% (to merge with health diagnostics firm)
-MUR -8.1% (energy stock weakness)
-TURB -6.8% (earnings, color)
-LEGN -4.2% (appoints Alan Bash as Interim CEO)
-XOM -2.9% (oil prices lower following President Trump delaying Iran operation)
-CVX -2.8% (oil prices lower following President Trump delaying Iran operation)
Positions: None.